Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Aplastic anaemia is a rare disease in which the bone marrow and the hematopoietic stem cells that reside there are damaged.
The report details the trend, potential and market size of Aplastic Anemia market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Aplastic Anemiamarket, defines the market attractiveness level of Aplastic Anemia market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Aplastic Anemia industry, describes the types of Aplastic Anemia market, the applications of major players and the market size, and deeply analyzes the current situation of the global Aplastic Anemia market and the development prospects and opportunities of Aplastic Anemia industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Aplastic Anemia market in Chapter 13.
By Player:
SOBI
Octapharma
Bluebird bio
Pfizer
Amgen
Bayer
Novo Nordisk
GlaxoSmithKline
CSL Limited
Shire
By Type:
Oral
Injection
By End-User:
Hospital
Drugs Store
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Aplastic Anemia Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Aplastic Anemia Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Aplastic Anemia Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Aplastic Anemia Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Aplastic Anemia Market Analysis and Outlook to 2022
-
7.1 Global Aplastic Anemia Consumption (2017-2022)
-
7.2 United States Aplastic Anemia Consumption (2017-2022)
-
7.3 Europe Aplastic Anemia Consumption (2017-2022)
-
7.4 China Aplastic Anemia Consumption (2017-2022)
-
7.5 Japan Aplastic Anemia Consumption (2017-2022)
-
7.6 India Aplastic Anemia Consumption (2017-2022)
-
7.7 South Korea Aplastic Anemia Consumption (2017-2022)
8 Region and Country-wise Aplastic Anemia Market Analysis and Outlook to 2028
-
8.1 Global Aplastic Anemia Consumption Forecast (2022-2028)
-
8.2 United States Aplastic Anemia Consumption Forecast (2022-2028)
-
8.3 Europe Aplastic Anemia Consumption Forecast (2022-2028)
-
8.4 China Aplastic Anemia Consumption Forecast (2022-2028)
-
8.5 Japan Aplastic Anemia Consumption Forecast (2022-2028)
-
8.6 India Aplastic Anemia Consumption Forecast (2022-2028)
-
8.7 South Korea Aplastic Anemia Consumption Forecast (2022-2028)
9 Global Aplastic Anemia Market Outlook by Types and Applications to 2022
-
9.1 Global Aplastic Anemia Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Aplastic Anemia Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Aplastic Anemia Market Outlook by Types and Applications to 2028
-
10.1 Global Aplastic Anemia Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Aplastic Anemia Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Aplastic Anemia Import and Export Analysis (Top 5 Countries)
-
11.1 Global Aplastic Anemia Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Aplastic Anemia Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Aplastic Anemia Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Aplastic Anemia Market Competitive Analysis
-
14.1 SOBI
-
14.1.1 SOBI Company Details
-
14.1.2 SOBI Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 SOBI Aplastic Anemia Product and Service
-
14.2 Octapharma
-
14.2.1 Octapharma Company Details
-
14.2.2 Octapharma Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Octapharma Aplastic Anemia Product and Service
-
14.3 Bluebird bio
-
14.3.1 Bluebird bio Company Details
-
14.3.2 Bluebird bio Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bluebird bio Aplastic Anemia Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Aplastic Anemia Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Aplastic Anemia Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Aplastic Anemia Product and Service
-
14.7 Novo Nordisk
-
14.7.1 Novo Nordisk Company Details
-
14.7.2 Novo Nordisk Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk Aplastic Anemia Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Aplastic Anemia Product and Service
-
14.9 CSL Limited
-
14.9.1 CSL Limited Company Details
-
14.9.2 CSL Limited Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 CSL Limited Aplastic Anemia Product and Service
-
14.10 Shire
-
14.10.1 Shire Company Details
-
14.10.2 Shire Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shire Aplastic Anemia Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Aplastic Anemia
-
Figure Aplastic Anemia Picture
-
Table Global Aplastic Anemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Aplastic Anemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Aplastic Anemia Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Aplastic Anemia Consumption by Country (2017-2022)
-
Figure United States Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Table Europe Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Figure China Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Figure Japan Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Figure India Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Figure South Korea Aplastic Anemia Consumption and Growth Rate (2017-2022)
-
Figure Global Aplastic Anemia Consumption Forecast by Country (2022-2028)
-
Figure United States Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Aplastic Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Aplastic Anemia Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Aplastic Anemia Export by Region (Top 5 Countries) (2017-2028)
-
Table SOBI (Foundation Year, Company Profile and etc.)
-
Table SOBI Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table SOBI Aplastic Anemia Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Aplastic Anemia Product and Service
-
Table Bluebird bio (Foundation Year, Company Profile and etc.)
-
Table Bluebird bio Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird bio Aplastic Anemia Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Aplastic Anemia Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Aplastic Anemia Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Aplastic Anemia Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Aplastic Anemia Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Aplastic Anemia Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Aplastic Anemia Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Aplastic Anemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Aplastic Anemia Product and Service
-
